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Abstract
The most common humoral immunodeficiencies in children
are selected IgA deficiency (IgAD) and common variable im -
munodeficiency (CVID). IgA deficiency is diagnosed based on
laboratory tests because the majority of patients demon-
strate no clinical symptoms. Standards for CVID diagnosis
include clinical symptoms, hypogammaglobulinemia (IgG and
often IgA), weak production of specific antibodies in response
to vaccination and disorders of cellular immunity. Humoral
immunodeficiencies are associated with autoimmunity in
about 30% of cases. Autoimmune diseases in children include
hematological (e.g. thrombocytopenia) and gastrointestinal
(GI) diseases (mainly celiac and Crohn’s disease). There are no
standards of diagnostic procedures of GI autoimmunity in
immunodeficiency patients. The screening of GI autoimmuni-
ty was performed in all children with humoral immunodefi-
ciencies including detection of antibodies for celiac disease
(anti-endomysial, tissue transglutaminase and gliadin),
Crohn’s disease (anti-Saccharomyces cerevisiae antigens, pan-
creatic cells) and ulcerative colitis (anti neutrophils cytoplasm,
goblet cells). The lowering of the limit for a positive value of
antibodies is postulated to adjust these results to weaker pro-
duction of antibodies due to immunodeficiency. This screen-
ing led to determining a group of children with present anti-
bodies independently of clinical symptoms. Careful moni toring
of antibodies and occurrence of clinical symptoms is suggest-
ed to diagnose as early as possible concomitant autoimmune
disease in children with immunodeficiency.
Streszczenie
Najczęstszymi niedoborami odporności humoralnej u dzieci
są izolowany niedobór IgA (IgA deficiency – IgAD) oraz pospo-
lity zmienny niedobór odporności (common variable immuno-
deficiency – CVID). Rozpoznanie IgAD ustala się na podstawie
wyników badań laboratoryjnych, natomiast rozpoznanie CVID
opiera się na standardach obejmujących objawy kliniczne i hi -
pogammaglobulinemię (IgG i często IgA), niski poziom swo-
istych przeciw ciał w odpowiedzi na szczepienia oraz zaburze-
nia odporności komórkowej. Schorzenia autoimmunizacyjne
współistnieją z niedoborami odporności u ok. 30% pacjentów.
U dzieci najczęściej stwierdza się zaburzenia hematologiczne
(np. małopłytkowość) i schorzenia przewodu pokarmowego,
w tym chorobę trzewną i Leśniowskiego-Crohna. Badania
przesiewowe w kierunku schorzeń autoimmunizacyjnych prze-
wodu pokar mowego obejmują wykrywanie przeciwciał typo-
wych dla choroby trzewnej (dla endomysium, transglutami-
nazy tkankowej i gliadyny), Leśniowskiego-Crohna (dla
anty genów Saccharomyces cerevisiae i komórek zewnątrzwy-
dzielniczych trzustki) oraz wrzodziejącego zapalenia jelita gru-
bego (dla cytoplazmy granulocytów, komórek śluzotwór-
czych). Postuluje się obniżenie progu uznawania wyników
oceny przeciwciał za dodatnie, aby uwzględnić niedobór od -
porności. Ocena obecności autoprzeciwciał pozwala na wyse-
lekcjonowanie dzieci z przeciwciałami bez względu na wystę-
powanie lub nie objawów klinicznych. Monitorowanie
poziomu przeciwciał oraz występowania objawów klinicznych
jest ważne dla wczesnego rozpoznania współistniejącej cho-
roby autoimmunizacyjnej u dzieci z niedoborami odporności.
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The most common humoral
immunodeficiencies in children
Selected IgA deficiency (sIgAD, IgAD) 
The frequency of this defect is unknown; estimation
of its occurrence from 1 : 400 to 1 : 700 children depends
on the country of the study and number of children
included in the study group [1]. The majority of children
(about 80%) have no clinical symptoms of selected IgA
deficiency. The remaining children show recurrent infec-
tions of the respiratory and gastrointestinal system.
Abdominal pain, problems with jejunum motility (con-
stipation or diarrhea), feeling of discomfort and disten-
tion are 10–20 times more frequent in sIgAD than in
healthy children in the same age. The lack of secretory
IgA produced and secreted by B lymphocytes present in
free lymphoid tissue under mucous membrane of the
gastrointestinal tract is associated with these symp-
toms [2–4]. The basic role of secretory IgA is protection
of mucous membranes and selection of antigens pass-
ing this barrier. Moreover, the secretory IgA inhibits the
expression of proinflammatory bacterial epitopes, limit-
ing the presence of bacterial pathogens to special deter-
mined regions of the jejunum mucous membrane, pre-
venting the binding of pathogens to epithelial cells and
helping in intraepithelial neutralization of pathogens
and other bacterial products [5]. In selected IgA defi-
ciency this immunoglobulin is replaced by IgG and IgM.
The lack of secretory IgA is associated not only with pro-
longed inflammatory diseases of the gastrointestinal
tract such as atrophic gastritis, Crohn’s disease or celiac
disease but also with infections, e.g. Helicobacter pylori,
Campylobacter or Giardia lamblia, showing similar
symptoms. These infections are more frequent in adults
with sIgAD than in children. In the histology of biopsy
from people during Helicobacter pylori or Campylobacter
infection, the flattening of jejunum villi suggests celiac
disease. However, the effective therapy of infection with
antibiotics leads to regeneration of villi, but in some
patients these infections are prolonged so the destruc-
tion of the jejunum mucous membrane is irreversible
due to chronic diarrhea. IgA helps in elimination of pa -
thogens from the surface of mucous membrane epithe-
lial cells so the lack of this immunoglobulin may main-
tain infection by facilitating the binding of pathogens to
the surface of epithelium [1, 2]. The prevalence of celiac
disease in children with sIgAD and familiar occurrence
of both diseases suggested a common genetic back-
ground of both diseases. Moreover, the haplotype of
HLA: A1, Cw7, B8, DR3, DQ2 is important for co-existence
of IgAD and celiac disease [2, 6]. However, the precise
analysis of frequency of celiac disease within the IgAD
population does not support this hypothesis because
the co-existence of celiac disease and sIgAD is lower
than expected based on the effect of a common genet-
ic background. Another hypothesis of association of celi-
ac disease and IgAD proposes an increase of B lympho-
cyte stimulating factors (B-lymphocyte stimulator (BLyS)
and a proliferation inducing ligand – APRIL) noted in
IgAD patients as an important factor. A new, large, in-
depth study did not reveal differences between the lev-
el of these factors in IgAD with or without concomitant
celiac disease [7]. It seemed, that the possibility of
destruction of the mucous membrane and occurrence of
clinical symptoms due to disturbed metabolism of
gliadin in the case of a lack of secretory IgA is more
probable [2]. In the histology of biopsy in celiac disease
the pattern of changes in the jejunum is similar in
patients with or without IgAD. A gluten-free diet (GFD) is
effective, despite sIgAD. 
The frequency of Crohn’s disease and ulcerative coli-
tis in people with IgAD is unknown [2, 8–11]. Moreover, in
adults with IgAD, nodular lymphoid hyperplasia (NLH) is
described as a separate clinical entity. The high amounts
of large nodules consisting of B lymphocytes producing
mainly IgM, located along mucous membrane of the gas-
trointestinal tract, lead to symptoms of malabsorption,
flattening of villi, and even jejunum occlusion [2]. The dif-
ferential diagnosis of inflammatory/autoimmune disease
of GI in sIgAD patients is very difficult because of over-
lapping of clinical symptoms and similar changes in his-
tology of jejunum biopsy.
Common variable immunodeficiency 
Common variable immunodeficiency (CVID) was pri-
marily described in adults, so the majority of data about
the clinical symptoms and course, clinical symptoms 
in concomitant diseases, are based on observations
from adult patients. The frequency of CVID is be tween 
1 : 25000 and 1 : 50000. Diagnosis is based on exclusion
of known causes of noted clinical symptoms and hy -
pogammaglobulinemia. Criteria of CVID are lower level
of IgG only or IgG and a second immunoglobulin (IgA or
IgM), low level of specific antibodies to vaccination anti-
gens, and disorders in cellular immunity in marked per-
centage of patients. A lower number of T lymphocytes,
adverse proportion between CD4 and CD8 subpopula-
tions, and low proliferation indexes after mitogen and
antigen stimulation are observed [1, 2, 11–13]. Clinical
symptoms of CVID are different in children and adults
[14]. In patients diagnosed as adults chronic sinusitis,
bronchiectasis, and chronic lung disease are often
observed, while in children diagnosed with CVID these
symptoms are very rare. Measurement of immunoglob-
ulin levels in children is due to frequent infections of the
respiratory tract, otitis, sinusitis (in older children) char-
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acterized by prolonged course, and weak response to
antibiotics. Low levels of immunoglobulins (according to
age-related level) and no increase in response to infec-
tion are the basis of humoral immunodeficiency diagno-
sis – common variable immunodeficiency (CVID). 
Autoimmune diseases occurred in 20–30% of CVID
patients as hematological symptoms, mainly thrombo-
cytopenia, leukopenia, and neutropenia [9, 15]. After he -
matological symptoms, autoimmune and chronic
inflammatory diseases of the gastrointestinal tract, e.g.
Crohn’s disease, celiac disease, atrophic gastritis with
megaloblastic anemia, autoimmune hepatitis, ulcerative
colitis and nodular lymphoid hyperplasia (NLH), are not-
ed in these patients [2, 5, 11, 16, 17]. This sequence of
autoimmune diseases in CVID (first – haematological
symptoms, second – GI tract, other – less frequent) is
based on data from adult patients. There are a few
observations from children about co-existence of auto -
immunity and CVID. Thrombocytopenia, neutropenia,
hemolytic anemia and gastrointestinal tract disease
(inflammatory bowel disease – IBD, celiac disease) are
frequent in children but the proportions between them
and frequency of particular diseases are not known.
Autoimmunity of the gastrointestinal tract in children
with CVID is second in frequency after hematologic
symptoms, like in adults. However, in children with CVID
celiac disease, Crohn’s disease and hepatitis are com-
mon while in adults rheumatoid arthritis, skin diseases,
systemic lupus erythematosus, primary biliary cirrhosis,
pernicious anemia, and atrophic gastritis are more 
frequent [2]. The diagnosis of autoimmune disease in -
cludes clinical symptoms and circulating antibodies for
described cellular and tissue antigens. In CVID the sero-
logical diagnosis is problematic because of 2 reasons:
first, low production of specific antibodies typical for
humoral immunodeficiency; and second, lack of gA in
IgAD and in some CVID patients. In autoimmune/inflam-
matory disease of the GI tract antibodies in IgA class
were clinically significant as a consequence of IgA’s role
in GI mucous membranes. Considering the results of
antibody detection as significant for diagnosis in IgA
class only, in the case of CVID patients may lead to false
negative results. Now, tests detecting antibodies are
performed in both (IgA and IgG) classes of immunoglob-
ulins as routine. Moreover, the histology of the jejunum
in IBD in patients with IgAD and CVID shows some dif-
ferences as compared to IBD histology in patients with-
out immunodeficiency. It seems that disturbances in B
lymphocyte ontogeny in CVID, e.g. abnormal process 
of maturation, incomplete hypermutation, lack or low
number of B memory cells, are associated with a differ-
ent pattern of histology of tissues involved in the au -
toimmune process [2, 17, 18]. In jejunum biopsy from
patients with CVID and celiac disease or Crohn’s disease
the number of B lymphocytes in the infiltration is low,
and plasmocytes are singular or absent. This different
histology is so typical and characteristic for CVID pa -
tients that these diseases are called celiac-like disease
and Crohn’s-like disease to discriminate between
patients with or without immunodeficiency [2].
Deficiency of specific antibody 
synthesis 
In this deficiency the level of immunoglobulin is
within the normal range but the clinical course of infec-
tions suggests a deficiency. The most common infec-
tions such as tonsillitis, pharyngitis, and bronchitis
become severe, almost septic in otherwise healthy chil-
dren. Levels of IgG and subclasses of IgG are within the
normal range, and parameters of cellular immunity are
without disorders. The immunodeficiency is diagnosed
based on the low level of specific antibodies to vaccina-
tion antigens only [2, 9]. The low level of specific anti-
bodies suggests disorders of their production and is the
main symptom of this immunodeficiency. Similar to
CVID, this type of immunodeficiency is an indication for
regular immunoglobulins’ substitution [12].
Immunoglobulins’ substitution
The regular substitution of immunoglobulins in
a dose of 0.4–0.5 g/kg b.w./month intravenously or sub-
cutaneously delivers the specific antibodies to common
pathogens. Decrease in frequency and milder clinical
course of infections are the main goals to obtain with
immunoglobulins’ substitution. In the case of IBD in
CVID the regular substitution is effective in prophylaxis
of infections but has no influence on the course of con-
comitant autoimmune/inflammatory GI disease. One
plausible explanation indicated lack of possibility to
reach the epithelial jejunum surface by immunoglobulin
molecules [2]. However, in other autoimmune diseases
co-existing with CVID, e.g. chronic thrombocytopenia or
neutropenia, regular substitution increased the number
of platelets or neutrophils in CVID patients, although
the low dose of IgG is below the proved suppressive
effect on the autoimmune process [2]. It might be the
effect of anti-inflammatory activity of IgG, even in a pro -
phylactic dose. The suppressive effect of immunoglobu-
lin infusion is associated with a high dose (1.0–2.0 g/kg
b.w./therapy). This high-dose therapy is recommended
in acute thrombocytopenia (e.g. associated with viral
infection), Kawasaki disease, chronic polyneuropathy
with demyelinization, hemolytic anemia and others [12].
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Diagnosis of gastrointestinal tract
autoimmune diseases
Standards of autoimmunity of GI 
diagnostic procedures
The standard diagnosis of GI autoimmunity is per-
formed in people with clinical symptoms and consists of
laboratory tests (detection of autoantibodies), imaging
procedures (gastroscopy, colonoscopy and other radio-
logical methods) and histology of jejunum mucous me -
mbrane biopsy [19–21]. The laboratory markers are help-
ful in early diagnosis preceding the onset of severe
clinical symptoms in many patients. In recent years, the
detection of antibodies associated with the GI autoim-
mune process is commonly used for screening in the risk




Typical clinical symptoms for celiac disease are
observed in about 20% of patients (classic form of dis-
ease) [22]. In the remaining patients, clinical symptoms
suggest jejunum dysfunction and malabsorption syn-
drome leading to hypochromic anemia, occurrence of
aphthae and aphthous stomatitis, osteopenia, some-
times osteoporosis with bone fractures, low level of iron
resistant to oral therapy, and hypoproteinemia. These
symptoms are not directly associated with the gastroin-
testinal tract. Diagnosis of latent, silent or atypical form
of celiac disease, often in older children, teenagers and
adults, is based on complex procedures. The genetic
background of celiac disease is associated with expres-
sion of HLA-DQ2 and HLA-DQ8 determinants, which
explains the familiar predisposition to this disease.
Commonly used antibodies tested during diagnostic
procedures for celiac disease include antibodies against
gliadin, tissue transglutaminase and endomysium. Anti-
bodies in IgA class are clinically significant with the
exception of IgAD and CVID with IgA deficiency, when
antibodies in IgG class are significant. Now, there are
commercial tests offering assays in both classes of
immunoglobulins [23–25].
Antibodies to gliadin are detected with indirect fluo-
rescence in serum diluted 1 : 10 in both IgG and IgA im -
munoglobulin classes. Sensitivity and specificity of this
test are 100% in IgG and 95–99% in IgA. Gluten-free diet
(GFD) resulted in a decrease of antibody levels within 
3–6 months, often below the detection level [23, 24].
Endomysial antibodies are associated with complex
gliadin-reticulin and tissue transglutaminase facilitating
complex formation. Indirect fluorescence with serum
diluted 1 : 10 is the best method. The serial dilution of
positive serum is a semi-quantitative assay of antibody
levels which is used for monitoring GFD effects. Sensi-
tivity and specificity of these antibodies are 100% in IgA
class, lower in IgG class [23, 24].
Antibodies against tissue transglutaminase are
assayed with the ELISA quantitative method in IgA and
IgG class, which is important for IgAD patients with celi-
ac disease. Sensitivity is estimated as 96%, specificity as
98% [23, 24]. 
Crohn’s disease
Antibodies against tissue transglutaminase are not-
ed not only in serum of celiac patients but in about 20%
of patients with Crohn’s disease. Now, antibodies
against Saccharomyces cerevisiae antigens (ASCA) are
used as the most typical and specific for Crohn’s dis-
ease. The quantitative method (ELISA) is commonly
used as more precise and objective than the previously
used qualitative method (indirect fluorescence). Anti-
bodies in IgA class are clinically significant, but for peo-
ple with IgAD or CVID without IgA, antibodies in IgG
class are significant. Specificity of ASCA antibodies is
estimated as 99%, sensitivity as 79%. 
Indirect fluorescence is used for detection of anti-
bodies against exocrine pancreas tissue (PAB) and prod-
uct of pancreatic cells (drop like fluorescence). Specifici-
ty of these antibodies for diagnosis of Crohn’s disease is
about 93%, and the predictive value compared to ASCA
about 77% [26]. 
Ulcerative colitis
The detection of antibodies in serological diagnosis
of ulcerative colitis (UC) has been used for a few years.
Antibodies against mucin produced by goblet cells
(GAB), against neutrophil myeloperoxidase (ANCA) and
antinuclear (ANA) are assayed with indirect immunoflu-
orescence or ELISA. The GAB are noted in about 80% of
patients with UC. 
Jejunum histology
In celiac disease changes in the jejunum are classi-
fied according to the Marsh, Oberhuber and Corazza
scale [24]. The most common Marsh scale includes the
number of intraepithelial lymphocytes (IEL), proportion
of crypt number and villi height, and structure and
height of villi. Patients with clinical symptoms and
a positive serological test but without changes in
jejunum villi parameters are problematic (Marsh scale 0)
[27]. In these patients the electron microscopy seemed
to be a resolution and changes seen at microscopic lev-
el are diagnosed as microscopic enteritis [28, 29].
The typical pattern in chronic inflammatory bowel
disease consisted of infiltration, development of new
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lymphoid nodules, and increase of IEL number. In celiac
disease the infiltrations consist of T and B lymphocytes,
plasmocytes and a few monocytes. Interesting was the
high percentage of TCR γ/δ lymphocytes within T lym-
phocytes infiltrating the submucous level of the jejunum
wall. The high number of TCR γ/δ was higher when celi-
ac disease occurred in IgAD patients [30]. In celiac dis-
ease infiltrations are free from neutrophils often noted
in infiltrations typical for Crohn’s disease and UC. Pres-
ence of given cell populations within infiltrations is asso-
ciated with different profiles of cytokines, mainly proin-
flammatory, produced locally. Production of antibodies
by B cells present in infiltrations is induced by antigens
present in close contact with immunocompetent cells,
e.g. neutrophils dying in situ, which leads to production
of ANA and ANCA [20, 21].
Celiac disease in immunodeficiency
Diagnosis of celiac disease in humoral immunodefi-
ciency is difficult because of scanty and unspecific symp-
toms and because of overlapping of these symptoms,
e.g. periodic or prolonged diarrhea, and abdominal pain
caused by IgAD only, without concomitant celiac disease
[31, 32]. In children without immunodeficiency anti-
endomysial antibodies, antibodies to gliadin and tissue
transglutaminase are produced mainly in IgA class (im m-
unoglobulin of mucous membrane). These same anti-
bodies are produced in IgAD patients but in IgG class. In
patients with CVID, the problem of antibody production
is more complex due to IgA deficiency in a marked num-
ber of patients and weak production of antibodies in
response to antigens including autoantigens. However,
permanent presence of autoantigens in contact with
immunocompetent cells may be strong enough for
induction of antibody production, despite weaker func-
tion of the immune system. The level of these antibodies
is above the limit of a positive value, but lower than
observed in children without immunodeficiency.
Standard diagnostic procedures in celiac disease
consisted of serological tests detecting typical antibod-
ies in serum in patients with clinical symptoms sug-
gesting celiac disease and histology of jejunum biopsy.
In some patients, despite typical clinical symptoms, the
histology of the jejunum is negative [22, 27]. Submicro-
scopic study helps in individual cases showing very del-
icate but typical changes [29]. Following this, clinicians
suggest GFD when the clinical symptoms are present
without histological proof of celiac disease in typical
analysis of biopsy. Moreover, the submicroscopic
changes are also an indication for GFD [29].
Observations of GFD effects in patients with CVID
showed resistance to this therapy in about 20% of pa -
tients. Within this group of CVID patients lack or very
low level of IgA was frequent. Jejunum dysfunction and
malabsorption syndrome progress despite restricted
GFD, leading to inhibition of growth and development of
malnutrition.
Crohn’s disease and UC in immunodeficiency 
Adults with CVID and gastrointestinal involvement
demonstrate chronic diarrhea in about 10% to 50% of
patients [2, 8, 12, 16, 18]. In children with IgAD, CVID diar-
rhea is less frequent but studied groups were small. The
bowel inflammatory disease in immunodeficient pa -
tients demonstrated different histology often compared
to lymphocytic colitis than typical Crohn’s disease or UC
[2]. Regular substitution of immunoglobulins does not
inhibit progress of inflammation, and does not help in
regeneration and healing of mucous membrane dam-
age. Hypotheses explaining the lack of effects of im -
munoglobulins' substitution are various, including defect
of regulatory T lymphocytes (Treg CD4/CD25/FoxP3), ef -
fects of different profiles of proinflammatory cy to kines
produced locally and, what seemed to be most interest-
ing, lack of possibility to reach the surface of the epithe-
lium by immunoglobulins given intravenously. This phe-
nomenon is important in patients with CVID and a low
level or lack of IgA [2]. 
In histology of jejunum from patients with CVID and
IBD, the cellular infiltrations consisted mainly of T lym-
phocytes with a low number of B lymphocytes and few
or no plasmocytes [2, 12]. Diagnosis of UC is often diffi-
cult in patients without immunodeficiency so this diag-
nosis in patients with CVID is much more problematic. 
In a study including 248 patients (children and adults)
with CVID, UC was noted only in 7 patients. However, in
10 other patients demonstrating clinical symptoms of
inflammation the final diagnosis was not established. It
showed the difficulties in differential diagnosis of
jejunum diseases in immunodeficient patients [11].
Differential diagnosis – “collagenous sprue”, 
microscopic and autoimmune, chronic bowel 
inflammation 
Collagenous sprue (CS) is a rare, severe disorder of
jejunal function (absorption process mainly) with a low
number of crypts, flattening of villi, and collagen de -
posits under the epithelial cell layer containing cellular
elements within. This histology is typical for diagnosis of
CS [33]. However, similar symptoms, e.g. histology with
flattening of villi, lack of response to GFD (observation
during at least 1 year), are noted in refractory celiac dis-
ease (RCD), which might suggest wrong diagnosis and
delay in CS diagnosis. Precise diagnosis is very impor-
tant as CS is a progressive disease leading to se vere
malabsorption syndrome, cachexia and death. Therapy
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is based on steroids, immunosuppression and total pari-
etal nutrition [32]. Up to now this disease has been not-
ed in patients without immunodeficiency, although CS
symptoms overlapping diet refractory celiac disease
with cachexia may suggest CS in these patients.
Autoimmune enteropathy (AE) was separated as
a new entity in young children with chronic diarrhea and
antibodies to epithelial cells (anti-enterocyte antibodies)
as a marker of the autoimmune process. The first case
was described in a child with IgAD, which suggests the
association between AE and immunodeficiency. The
majority of patients were boys diagnosed in the first
year of life [28]. Anti-enterocyte antibodies seemed to
be important for induction and supporting the process
of jejunum mucous damage but it has not been proved
yet. However, in other prolonged inflammatory diseases,
e.g. Crohn’s, celiac disease or UC, these antibodies are
absent, supporting the idea of a separate diagnostic and
clinical entity [28]. 
Microscopic enteritis (ME) was used first in adults
showing malabsorption symptoms without inflammation
characteristics, without changes in villi structure or ulcers
present in light microscopy [29]. Such enteritis might
explain symptomatic celiac disease without changes in
jejunum mucous (Marsh scale 0) due to overlapping
symptoms [24, 27, 29]. Differentiation between these two
syndromes is possible with electron microscope assay.
Submicroscopic changes are more typical for celiac dis-
ease with minimal mucous damage (Marsh 0). 
Algorithm of differential diagnosis 
in children with immunodeficiency
Children with immunodeficiency and gastrointestinal
tract involvement demonstrate abdominal pain, mete-
orism, feelings of discomfort, lack of appetite, periodic
diarrhea or constipation. In other children without gastric
symptoms the inhibition of growth and underweight are
noted, suggesting discrete malfunction of the jejunum.
High prevalence of gastrointestinal autoimmune dis-
eases in this group of children is an indication for
a screening test of typical autoantibodies in serum.
Observations of preserved autoantibodies’ production in
immunodeficiency such as CVID and IgAD modify the
common view about the possibility of the immune sys-
tem to respond to antigens. Studies of antibody pro-
duction are focused on vaccination antigens given 2 or 
3 times in a single dose in precise periods of time. The
low function of memory in CVID or disorders of specific
antibody synthesis resulted in low titers of specific anti-
bodies. In the autoimmune process, autoantigen is pres-
ent permanently in contact with immunocompetent
cells, stimulating them effectively to production of anti-
bodies. The final level of antibodies in serum is often low-
er than in children without immunodeficiency. In conse-
quence of this the limit of a positive result should be
lowered. Considering low levels of antibodies as positive
results, children with a probable autoimmune process are
selected for further tests, repeating the antibody assay
after 4–6 months, with careful clinical observations,
undertaking diagnostic procedures without delay [34].
Presence of antibodies, even at low levels, and discrete,
unspecific clinical symptoms are indications for a diag-
nostic procedure including histology of jejunum biopsy
without repeating the antibody assay. 
In celiac disease diagnosed in children with IgAD,
restricted GFD is effective as in children without IgAD. In
CVID the response to GFD in the majority of patients is
good but in about 20% of patients resistance to GFD
and progress of symptoms are noted. The course of dis-
ease in these patients is severe, and time to obtain
remission is longer. Therapy with steroids, monoclonal
antibodies against TNF and immunosuppression might
be effective. 
Crohn’s disease is more frequent than UC in children
with immunodeficiency. Untypical clinical course results
in delay of diagnostic procedures. Antibodies detected
before severe clinical symptoms signal the autoimmune
process and, in consequence, introduction of therapy
which diminishes the development of malabsorption
syndrome and jejunum damage. Regular substitution of
immunoglobulins in CVID prevents infections and pro-
tects patients during steroid or immunosuppressive
therapy for Crohn’s disease or UC. 
Our observations
Detection of antibodies typical for Crohn’s disease
and celiac disease was performed in 43 children diag-
nosed with CVID and 63 children with IgAD. Antibodies
typical for celiac disease (against endomysium tissue
transglutaminase and gliadin) were noted in 14 children
(3 diagnosed with CVID, 11 with IgAD). Two of them were
diagnosed as celiac despite weak and unspecific clinical
symptoms. Antibodies typical for Crohn’s disease were
noted in 16 children (7 diagnosed with CVID, 9 with
IgAD). The titer of antibodies was close to 20 units (bor-
der level for a positive result) but because of immunod-
eficiency was considered as positive followed with cli-
nical careful observations and monitoring antibodies
every 4–6 months.
Based on our observations and results of the study
we suggest that in patients with immunodeficiency and
gastrointestinal symptoms indicating an autoimmune or
inflammatory process, the diagnostic procedures and
therapy may need modifications of general standard
methods and working out new standards.
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